Table 3

HIV-1 subtypes and distribution of resistance-associated mutations among 16 patients with first-line ART failure attending three health centers in Djibouti city between October and December 2009
SEX CD4 SUBTYPE VL (cp/mL) TREATMENT NRTI NNRTI Major Mutation PI Minor Mutation PI
20 F 62 C 630 000 AZT/3TC/EFV None None None None
21 M 92 C 220 000 AZT/3TC/EFV None None None None
22 F 346 C 1 900 AZT/3TC/EFV None None None None
23 M 176 C 21 000 AZT/3TC/EFV None None None None
24 F 220 C 3270 AZT/3TC/EFV None None None None
25 F 243 C 7 500 AZT/3TC/EFV None None None None
26 F 103 C 413 000 D4T/3TC/NVP None K101Q, Y181C None None
27 M 52 C 26 000 AZT/3TC/EFV M184V K103N None None
28 M 249 C 213 000 D4T/3TC/EFV D67N, M184V, L210W, T215Y Y188L, G190A None None
29 F 230 C 1 080 000 AZT/3TC/EFV M41L, D67N, L74V, M184V, L210W, T215Y K103N, G190A, H221Y, M230L None None
30 F 140 CRFO2_AG 168 000 D4T/3TC/EFV None None None None
31 F 250 CRF02_AG/C 72 720 AZT/3TC/NVP K70KR, M184V, K219R K103N None None
32 M 92 CRFO2_AG 21 000 AZT/3TC/EFV T69N V179E, Y188L None L10V
33 M 88 CRFO2_AG 7 100 AZT/3TC/EFV M184V K103N None L10V
34 F 208 B 1 300 D4T/3TC/NVP A62V None None None
35 M 105 B 4 837 560 AZT/3TC/EFV A62V, M184V, T215F, K219Q None None None

Elmi Abar et al.

Elmi Abar et al. Diagnostic Pathology 2012 7:138   doi:10.1186/1746-1596-7-138

Open Data